p330d, also known as CENP-F, is a newly characterized cell cycle speci
fic nuclear autoantigen which is associated both with the centromeres
and the nuclear matrix. It is expressed in low amounts in G0/G1-cells
and accumulates in the nuclear matrix during S-phase with a maximum ex
pression in G2/M-cells. In the present study we have investigated if p
330d/CENP-F could be used as a marker for proliferation in different h
uman malignancies. A flow cytometric method was developed by which p33
0d/CENP-F expression and DNA-content could be assessed on hematopoieti
c and solid tumors. Twenty-four different human hematopoietic malignan
cies, 12 breast cancers, and several cell Lines were analyzed and the
number of p330d/CENP-F positive cells and the S-phase fraction were de
termined. The percentage of p330d/CENP-F positive cells correlated wit
h the fraction of S-phase cells in all human malignancies tested. Vari
ous cell lines revealed a similar cell cycle specific distribution. Th
e association of p330d/CENP-F with the nuclear matrix facilitated the
flow cytometric analysis of this protein due to its resistance to diff
erent preparation and fixation procedures. In summary, p330d/CENP-F se
ems to be a potentially valuable proliferation marker which can be app
lied to different tumors. (C) 1996 Wiley-Liss, Inc.